Genentech, Inc., A Member of the Roche Group
Registered Principal Details
Business Or Interest:
Biotechnology and Pharmaceuticals
Lobbying Interests:
Matters related to biotechnology and pharmaceuticals
CEO Name:
Ashley Magargee
Biotechnology and Pharmaceuticals
Lobbying Interests:
Matters related to biotechnology and pharmaceuticals
CEO Name:
Ashley Magargee
Contact
JH
Joseph Hrdlicka
2350 Kerner Blvd., Suite 250
San Rafael, CA 94901
4153896800
genentech@nmgovlaw.com
https://www.gene.com/
2350 Kerner Blvd., Suite 250
San Rafael, CA 94901
4153896800
genentech@nmgovlaw.com
https://www.gene.com/
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 773
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
1/3/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
For
Notification Date1/3/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 100
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
3/17/2023
First Communication Date
3/16/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
For
Notification Date3/17/2023
First Communication Date
3/16/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Senate Bill 737
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
12/20/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
For
Notification Date12/20/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Application of prescription drug payments to health insurance cost-sharing requirements
Application of prescription drug payments to health insurance cost-sharing requirements
Action Intended To Affect
Legislative matter
Notification Date
3/17/2023
First Communication Date
3/15/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Comments
Meeting with Representative Robert Wittke & Senator Julian Bradley on 3/15/23 to discuss matters regarding SB.100
Legislative matter
Notification Date
3/17/2023
First Communication Date
3/15/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Comments
Meeting with Representative Robert Wittke & Senator Julian Bradley on 3/15/23 to discuss matters regarding SB.100
Development, drafting or introduction of a proposal relating to
Application of prescription drug payments to health insurance cost-sharing requirements
Application of prescription drug payments to health insurance cost-sharing requirements
Action Intended To Affect
Legislative matter
Notification Date
3/17/2023
First Communication Date
3/16/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Comments
Meeting with Senators Devin LeMahieu, & Joan Ballweg on 3/16/23 to discuss matters regarding SB.100
Legislative matter
Notification Date
3/17/2023
First Communication Date
3/16/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Comments
Meeting with Senators Devin LeMahieu, & Joan Ballweg on 3/16/23 to discuss matters regarding SB.100
Total Lobbying Effort
| 2023 January - June |
2023 July - December |
2024 January - June |
Total | |
|---|---|---|---|---|
| Total Lobbying Expenditures | 2023 January - June $2,000.00 |
2023 July - December $0.00 |
2024 January - June $0.00 |
Total $2,000.00 |
| Total Hours Communicating | 2023 January - June 2.00 |
2023 July - December 0.00 |
2024 January - June 0.00 |
Total 2.00 |
| Total Hours Other | 2023 January - June 0.00 |
2023 July - December 0.00 |
2024 January - June 0.00 |
Total 0.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 100% |
2023 July - December |
2024 January - June |
2024 July - December |
Total 100% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
No topics found.
Minor Efforts
No minor efforts found.
Other Matters
No other matters found.